Cargando…
High frequency of cerebrospinal fluid autoantibodies in COVID-19 patients with neurological symptoms
BACKGROUND: COVID-19 intensive care patients can present with neurological syndromes, usually in the absence of SARS-CoV-2 in cerebrospinal fluid (CSF). The recent finding of some virus-neutralizing antibodies cross-reacting with brain tissue suggests the possible involvement of specific autoimmunit...
Autores principales: | Franke, Christiana, Ferse, Caroline, Kreye, Jakob, Reincke, S. Momsen, Sanchez-Sendin, Elisa, Rocco, Andrea, Steinbrenner, Mirja, Angermair, Stefan, Treskatsch, Sascha, Zickler, Daniel, Eckardt, Kai-Uwe, Dersch, Rick, Hosp, Jonas, Audebert, Heinrich J., Endres, Matthias, Ploner, J. Christoph, Prüß, Harald |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The Author(s). Published by Elsevier Inc.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7834471/ https://www.ncbi.nlm.nih.gov/pubmed/33359380 http://dx.doi.org/10.1016/j.bbi.2020.12.022 |
Ejemplares similares
-
Intravenous immunoglobulins for treatment of severe COVID-19-related acute encephalopathy
por: Huo, Shufan, et al.
Publicado: (2022) -
Do cross-reactive antibodies cause neuropathology in COVID-19?
por: Kreye, Jakob, et al.
Publicado: (2020) -
Brain antibody sequence evaluation (BASE): an easy-to-use software for complete data analysis in single cell immunoglobulin cloning
por: Reincke, S. Momsen, et al.
Publicado: (2020) -
Antigenic imprinting in SARS‐CoV‐2
por: Reincke, S. Momsen, et al.
Publicado: (2022) -
Affinities of human NMDA receptor autoantibodies: implications for disease mechanisms and clinical diagnostics
por: Ly, Lam-Thanh, et al.
Publicado: (2018)